Mamta Kapoor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mamta Kapoor has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alex Mariakakis
Department of Computer Science, University of Toronto, Toronto, Ontario, Canada
1 shared publication - Brenna Li
Computer Science, University of Toronto, Canada
1 shared publication - Catherine Ji
Research and Innovation, North York General Hospital, 4001 Leslie St., Room LE-140, Toronto, ON M2K 1E1, Canada; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, 500 University Avenue, 5th Floor, Toronto, Ontario M5G 1V7, Canada; Toronto Western Family Health Team, University Health Network, 440 Bathurst Street, 3(rd) Floor, Toronto, ON M5T 2S6, Canada
1 shared publication - Christine Papoushek
University Health Network, Department of Pharmacy, Toronto, Ontario, Canada
1 shared publication - Christopher Chiu
University of Toronto, Toronto, ON, Canada
1 shared publication - Debbie Kwan
University Health Network, Department of Pharmacy, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 11 May 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-24
Beyond the Waiting Room: Patient's Perspectives on the Conversational Nuances of Pre-Consultation Chatbots
Pre-consultation serves as a critical information exchange between healthcare providers and patients, streamlining visits and supporting patient-centered care. Human-led pre-consultations offer many benefits, yet they require significant time and energy from clinical staff. In this work, we identify design goals for pre-consultation chatbots given their potential to carry out human-like conversations and autonomously adapt their line of questioning. We conducted a study with 33 walk-in clinic patients to elicit design considerations for pre-consultation chatbots. Participants were exposed to one of two study conditions: an LLM-powered AI agent and a Wizard-of-Oz agent simulated by medical professionals. Our study found that both conditions were equally well-received and demonstrated comparable conversational capabilities. However, the extent of the follow-up questions and the amount of empathy impacted the chatbot’s perceived thoroughness and sincerity. Patients also highlighted the importance of setting expectations for the chatbot before and after the pre-consultation experience.
- 11 May 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-24
Open AccessBeyond the Waiting Room: Patient's Perspectives on the Conversational Nuances of Pre-Consultation Chatbots
Pre-consultation serves as a critical information exchange between healthcare providers and patients, streamlining visits and supporting patient-centered care. Human-led pre-consultations offer many benefits, yet they require significant time and energy from clinical staff. In this work, we identify design goals for pre-consultation chatbots given their potential to carry out human-like conversations and autonomously adapt their line of questioning. We conducted a study with 33 walk-in clinic patients to elicit design considerations for pre-consultation chatbots. Participants were exposed to one of two study conditions: an LLM-powered AI agent and a Wizard-of-Oz agent simulated by medical professionals. Our study found that both conditions were equally well-received and demonstrated comparable conversational capabilities. However, the extent of the follow-up questions and the amount of empathy impacted the chatbot’s perceived thoroughness and sincerity. Patients also highlighted the importance of setting expectations for the chatbot before and after the pre-consultation experience.
- Open Access
- 1 January 2024
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 15
Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study
Background: Depression affects approximately 280 million individuals globally and it is a leading cause of disability. Despite effective medication options, 50% of patients prematurely discontinue antidepressants within 6 months. We sought to understand patients’ perspectives regarding their needs and expectations related to antidepressants. Objectives: To identify and describe enablers and barriers that influence adult patients’ medication adherence in depression treatment and to explore patients’ educational needs on initiating or continuing antidepressant therapy. Methods: Qualitative descriptive study was conducted using individual, semi-structured interviews of adult patients with depression who were prescribed an antidepressant within 3 months of study recruitment at an urban primary care clinic in Toronto, Canada. Thirteen participants were interviewed. Interviews were recorded and transcribed verbatim for inductive thematic analysis. Results: Six themes emerged: safety and effectiveness of antidepressant, understanding of depression and its management, medication administration, healthcare experiences in the treatment of depression, and social influences and relationships. Barriers to adherence included adverse effects of antidepressants, preference for non-pharmacological therapies, uncertainty about therapeutic effects, and social stigma. In contrast, enablers were positive responses from antidepressants, fear of relapse, reminder aids, established routine, and a trusting patient-provider relationship. Participants desired access to reliable, evidence-based, and personalized educational information delivered through verbal, written, and digital formats to support antidepressant adherence. Conclusion: To overcome the identified barriers, educational strategies should involve both patients and their prescribers to identify patient-specific needs and treatment goals, engage in shared decision-making, and maintain consistent follow-up to support antidepressant adherence.
- 1 January 2024
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 15
Open AccessPatient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study
Background: Depression affects approximately 280 million individuals globally and it is a leading cause of disability. Despite effective medication options, 50% of patients prematurely discontinue antidepressants within 6 months. We sought to understand patients’ perspectives regarding their needs and expectations related to antidepressants. Objectives: To identify and describe enablers and barriers that influence adult patients’ medication adherence in depression treatment and to explore patients’ educational needs on initiating or continuing antidepressant therapy. Methods: Qualitative descriptive study was conducted using individual, semi-structured interviews of adult patients with depression who were prescribed an antidepressant within 3 months of study recruitment at an urban primary care clinic in Toronto, Canada. Thirteen participants were interviewed. Interviews were recorded and transcribed verbatim for inductive thematic analysis. Results: Six themes emerged: safety and effectiveness of antidepressant, understanding of depression and its management, medication administration, healthcare experiences in the treatment of depression, and social influences and relationships. Barriers to adherence included adverse effects of antidepressants, preference for non-pharmacological therapies, uncertainty about therapeutic effects, and social stigma. In contrast, enablers were positive responses from antidepressants, fear of relapse, reminder aids, established routine, and a trusting patient-provider relationship. Participants desired access to reliable, evidence-based, and personalized educational information delivered through verbal, written, and digital formats to support antidepressant adherence. Conclusion: To overcome the identified barriers, educational strategies should involve both patients and their prescribers to identify patient-specific needs and treatment goals, engage in shared decision-making, and maintain consistent follow-up to support antidepressant adherence.